4//SEC Filing
Mazabraud Yann 4
Accession 0001104659-25-035516
CIK 0001649904other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:30 PM ET
Size
13.4 KB
Accession
0001104659-25-035516
Insider Transaction Report
Form 4
Mazabraud Yann
EVP, Head of International
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-04-15−2,500→ 7,500 total→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2025-04-14+10,375→ 32,995 total - Exercise/Conversion
Common Stock
2025-04-15+11,405→ 44,400 total - Exercise/Conversion
Restricted Stock Units
2025-04-14−10,375→ 20,750 total→ Common Stock (10,375 underlying) - Exercise/Conversion
Restricted Stock Units
2025-04-15−8,905→ 0 total→ Common Stock (8,905 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date.
- [F3]The restricted stock units have vested in full on April 15, 2025. The restricted stock units have no expiration date.
- [F4]The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001774702
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:30 PM ET
- Size
- 13.4 KB